Chinese device market penetration enhanced by purchase financing -- CHINDEX president.
This article was originally published in The Gray Sheet
Executive Summary
U.S. THIRD-PARTY FINANCING OF DEVICE PURCHASES BY HOSPITALS IN CHINA would help bolster a declining U.S. market share in the expanding Chinese medical device market, Roberta Lipson, CEO and president, U.S.-China Industrial Exchange (CHINDEX), said Dec. 12 at the Health Industry Manufacturers Association's 1996 "Emerging Market" conference in Washington D.C. "The answer to the question of financing is the answer to the Chinese market these days and will continue to be over the next few years," Lipson asserted.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.